Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.verified

NWPHF

Price:

$20

Market Cap:

$272.37M

Newron Pharmaceuticals S.p.A. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and advancing treatments for disorders affecting the central and peripheral nervous systems, as well as pain conditions. Operating in both Italy and the United States, the company's portfolio includes Xadago (safinamide), an approved therapy for Parkinson's disease, which is also under investigation for levodopa-induced dyskinesia. Additionally, Newron is developing Evenamide for schizophrenia and its treatment-resistant form, and Ralfinamide for specific orphan indications in neuropathic pain. Established in 1999, Newron Pharmaceuticals S.p.A. maintains its headquarters i...[Read more]

Industry

Biotechnology

IPO Date

2017-08-30

Stock Exchange

OTC

Ticker

NWPHF

The ROE as of June 2026 (TTM) for Newron Pharmaceuticals S.p.A. (NWPHF) is 277.88%

According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current ROE is 277.88%. This represents a change of -41.10% compared to the average of 471.76% of the last 4 quarters.

Newron Pharmaceuticals S.p.A. (NWPHF) Historical ROE (quarterly & annually)

How has NWPHF ROE performed in the past?

The mean historical ROE of Newron Pharmaceuticals S.p.A. over the last ten years is 66.32%. The current 277.88% ROE has changed 318.99% with respect to the historical average. Over the past ten years (40 quarters), NWPHF's ROE was at its highest in in the December 2024 quarter at 1.74%. The ROE was at its lowest in in the December 2021 quarter at -187.90%.

Quarterly (TTM)
Annual

Average

66.32%

Median

-17.61%

Minimum

-479.59%

Maximum

1.09%

Newron Pharmaceuticals S.p.A. (NWPHF) ROE by Quarter and Year

Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.90%

Maximum Annual ROE = 1.09%

Minimum Annual Increase = -126.00%

Minimum Annual ROE = -479.59%

Quarterly (TTM)
Annual
YearROEChange
2025119.77%-88.98%
20241.09%1.90%
202354.25%-56.49%
2022124.68%-126.00%
2021-479.59%293.90%
2020-121.76%121.72%
2019-54.91%100.28%
2018-27.42%251.53%
2017-7.80%-74.54%
2016-30.63%-50.18%

Newron Pharmaceuticals S.p.A. (NWPHF) Average ROE

How has NWPHF ROE performed in the past?

The current ROE of Newron Pharmaceuticals S.p.A. (NWPHF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

420.21%

5-year avg

181.15%

10-year avg

66.32%

Newron Pharmaceuticals S.p.A. (NWPHF) ROE vs. Peers

How is NWPHF’s ROE compared to its peers?

Newron Pharmaceuticals S.p.A.’s ROE is less than Faron Pharmaceuticals Oy (45.13%), greater than AnGes, Inc. (-156.47%), greater than Hamilton Thorne Ltd. (-1.00%), greater than Opsens Inc. (-36.43%), less than Recce Pharmaceuticals Ltd (279.21%), greater than Adocia S.A. (-3796.57%), greater than Dialogue Health Technologies Inc. (-22.56%), less than NIOX Group Plc (10.14%), greater than Planet 13 Holdings Inc. (-112.30%), greater than Guerbet S.A. (-33.69%),

Build a custom stock screener for Newron Pharmaceuticals S.p.A. (NWPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Newron Pharmaceuticals S.p.A. (NWPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Newron Pharmaceuticals S.p.A.'s ROE?

How is the ROE calculated for Newron Pharmaceuticals S.p.A. (NWPHF)?

What is the highest ROE for Newron Pharmaceuticals S.p.A. (NWPHF)?

What is the 3-year average ROE for Newron Pharmaceuticals S.p.A. (NWPHF)?

What is the 5-year average ROE for Newron Pharmaceuticals S.p.A. (NWPHF)?

How does the current ROE for Newron Pharmaceuticals S.p.A. (NWPHF) compare to its historical average?